Re-irradiation in lung disease by SBRT: a retrospective, single institutional study

被引：11
|
作者：
Caivano, Donatella [1 ]
Valenani, Maurizio [2 ]
De Matteis, Sara [2 ]
Bonome, Paolo [2 ]
Russo, Ivana [3 ]
De Sanctis, Vitaliana [2 ]
Minniti, Giuseppe [4 ]
Osti, Mattia Falchetto [2 ]
机构：
[1] CNAO Natl Ctr Oncol Hadrontherapy, Dept Radiat Oncol, Str Campeggi 53, I-27100 Pavia, Italy
[2] Univ Rome Sapienza, St Andrea Hosp, Fac Med & Psicol, Dept Radiat Oncol, Via Grottarossa 1035-1039, I-00189 Rome, Italy
[3] UPMC San Pietro FBF, Ctr Radioterapia Alta Specializzaz, Via Cassia 600, I-00189 Rome, Italy
[4] Neuromed Mediterranean Neurol Inst, Via Atinense 18, I-86077 Pozzilli, IS, Italy
来源：
RADIATION ONCOLOGY | 2018年 / 13卷
关键词：
Re-irradiation; SBRT; Lung; Primary or metastatic disease; STEREOTACTIC ABLATIVE RADIOTHERAPY; RADIATION-THERAPY; CANCER; TUMORS;
D O I：
10.1186/s13014-018-1041-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: The loco regional relapse is frequent in the lung disease. The aim of this study was to evaluate the outcomes of re-irradiation by SBRT in terms of Local Control (LC) and toxicities. Methods: From April 2011 to December 2016, twenty-two patients received a re-irradiation by SBRT. Twenty-seven lesions were treated. The medium BED(10) of re-irradiation was 100.6 Gy (range: 48-151.2 Gy) and the medium EQD2 (10) was 93.8 Gy (range: 40-126 Gy). In the previous treatment the medium BED(10) was 97.2 Gy (range: 40-120 Gy), the medium EQD2(10) was 81 Gy (range: 32.5-100 Gy). The median time between the first and the second treatment was 18 months. Results: Local Control was reached in 18 out of 27 (66%) re-irradiated lesions, with rates of 67 and 54% at 1-year and 2-years respectively. The treatment was well tolerated; the maximum recorded toxicity was Grade 3. Conclusions: Re-irradiation by SBRT may represent an option for the treatment of lung disease with good results in terms of LC and toxicity.
引用
收藏
页数：8
相关论文
共 50 条
  • [41] SBRT re-irradiation after prior SBRT in pancreatic cancer-outcomes and a focus on stomach and bowel toxicity
    Duran, Jose F.
    Hurwitz, Martina
    Chapman, Tobias
    Abrams, Matthew J.
    JOURNAL OF RADIATION ONCOLOGY, 2020, 9 (3-4) : 235 - 241
  • [42] RE-EVALUATING SURGERY AND RE-IRRADIATION FOR LOCALLY RECURRENT PEDIATRIC EPENDYMOMA - A MULTI-INSTITUTIONAL STUDY
    Mak, David Y.
    Laperriere, Normand
    Ramaswamy, Vijay
    Bouffet, Eric
    Murray, Jeffrey C.
    McNall-Knapp, Rene Y.
    Bielamowicz, Kevin
    Paulino, Arnold C.
    Zaky, Wafik
    McGovern, Susan L.
    Fatih Okcu, M.
    Tabori, Uri
    Dirks, Peter B.
    Taylor, Michael D.
    Tsang, Derek S.
    Bavle, Abhishek
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S28 - S28
  • [43] Re-irradiation for osteoarthritis-retrospective analysis of 217 joints
    Hautmann, Matthias G.
    Rechner, Philipp
    Hipp, Matthias
    Neumaier, Ulrich
    Steger, Felix
    Pohl, Fabian
    Weber, Markus
    Koelbl, Oliver
    Suess, Christoph
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (12) : 1060 - 1067
  • [44] Re-irradiation for Recurrent Glioma: A Single Institution Review
    Harris, T. J.
    Kleinberg, L. R.
    McMillan, R.
    Terezakis, S.
    Holdhoff, M.
    Lim, M.
    Redmond, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S257 - S257
  • [45] Multi -Institutional Report of Re-Irradiation for Recurrent High -Grade Glioma
    Zarabi, H.
    Helis, C. A.
    Russell, G.
    Huang, J.
    Liu, W.
    Soltys, S. G.
    Mendoza, M.
    Braunstein, S. E.
    Salans, M. A.
    Wang, T. J. C.
    Gallitto, M.
    Shi, W.
    Cappelli, L.
    Shen, C.
    Young, M. D.
    Mignano, J. E.
    Halasz, L. M.
    Barbour, A. B.
    Masters, A. H.
    Chan, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S85 - S86
  • [46] Re-irradiation for humeral epicondylitis Retrospective analysis of 99 elbows
    Hautmann, Matthias G.
    Beyer, Lukas P.
    Hipp, Matthias
    Neumaier, Ulrich
    Steger, Felix
    Dietl, Barbara
    Evert, Katja
    Koelbl, Oliver
    Suess, Christoph
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 262 - 269
  • [47] Can fractionated stereotactic re-irradiation improve the outcome in patients with recurrent glioblastoma? Single institutional experience
    Ciammella, P.
    Galeandro, M.
    Podgornii, A.
    D'Abbiero, N.
    Botti, A.
    Iori, M.
    Iotti, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S785 - S785
  • [48] Salvage re-irradiation with single modality interstitial brachytherapy for the treatment of recurrent gynecological tumours in the pelvis: A multi-institutional study
    Raziee, H.
    D'Souza, D.
    Velker, V.
    Leung, E.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 266 - 266
  • [49] Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
    Marsha Reyngold
    Abraham J Wu
    Amanda McLane
    Zhigang Zhang
    Meier Hsu
    Nicholas F Stein
    Ying Zhou
    Alice Y Ho
    Kenneth E Rosenzweig
    Ellen D Yorke
    Andreas Rimner
    Radiation Oncology, 8
  • [50] Re-irradiation in head and neck cancers: A single institution prospective cohort study
    Salunkhe, R.
    Laskar, S. Ghosh
    Chakraborty, S.
    Gupta, T.
    Budrukkar, A.
    Murthy, V.
    Agarwal, J. P.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 23 - 23
12345